{"id":"https://openalex.org/W2189115774","doi":null,"title":"Original Article Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse","display_name":"Original Article Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2189115774","mag":"2189115774"},"language":"en","primary_location":{"id":"mag:2189115774","doi":null,"is_oa":false,"landing_page_url":"http://www.research.ed.ac.uk/portal/files/8262978/Angiotensin_II_inhibition_effect_on_Alzheimer_s_pathology_in_the_aged_triple_transgenic_mouse..pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044903723","display_name":"Linda Ferrington","orcid":"https://orcid.org/0000-0002-4333-687X","observed_orcids":["https://orcid.org/0000-0002-4333-687X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda Ferrington","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103373243","display_name":"Laura E. Palmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura E. Palmer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016566297","display_name":"Seth Love","orcid":"https://orcid.org/0000-0001-8683-3625","observed_orcids":["https://orcid.org/0000-0001-8683-3625"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seth Love","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8683-3625","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101750107","display_name":"Karen J. Horsburgh","orcid":"https://orcid.org/0000-0002-9620-3691","observed_orcids":["https://orcid.org/0000-0002-9620-3691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Horsburgh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9620-3691","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Paul A. Kelly","orcid":"https://orcid.org/0000-0001-6997-9788","observed_orcids":["https://orcid.org/0000-0001-6997-9788"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul A. Kelly","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6997-9788","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027119794","display_name":"Patrick G. Kehoe","orcid":"https://orcid.org/0000-0002-7542-1139","observed_orcids":["https://orcid.org/0000-0002-7542-1139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick G. Kehoe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7542-1139","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.15669398,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.7540000081062317},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.7379999756813049},{"id":"https://openalex.org/keywords/tau-pathology","display_name":"tau pathology","score":0.7710000276565552},{"id":"https://openalex.org/keywords/3xtg-ad-mice","display_name":"3xTg-AD mice","score":0.8069999814033508},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6800000071525574},{"id":"https://openalex.org/keywords/amyloid-precursor-protein","display_name":"amyloid precursor protein","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.693642795085907},{"id":"https://openalex.org/C44752575","wikidata":"https://www.wikidata.org/wiki/Q1417562","display_name":"Morris water navigation task","level":3,"score":0.5862438678741455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5777261853218079},{"id":"https://openalex.org/C31705614","wikidata":"https://www.wikidata.org/wiki/Q423510","display_name":"Amyloid precursor protein","level":4,"score":0.547325611114502},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5260460376739502},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5128757953643799},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.4800194799900055},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.46327611804008484},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.44846612215042114},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.43001481890678406},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.42207586765289307},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.41757112741470337},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41015928983688354},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.3973219096660614},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.36493536829948425},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.31086355447769165},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2974848747253418},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.17930153012275696},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.15289956331253052},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10729944705963135},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2189115774","doi":null,"is_oa":false,"landing_page_url":"http://www.research.ed.ac.uk/portal/files/8262978/Angiotensin_II_inhibition_effect_on_Alzheimer_s_pathology_in_the_aged_triple_transgenic_mouse..pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W1552526595","https://openalex.org/W1554181954","https://openalex.org/W1569630040","https://openalex.org/W1574183113","https://openalex.org/W1597238539","https://openalex.org/W1729585270","https://openalex.org/W1828947725","https://openalex.org/W1829976582","https://openalex.org/W1895881996","https://openalex.org/W1967464880","https://openalex.org/W1967645451","https://openalex.org/W1973755223","https://openalex.org/W1977466782","https://openalex.org/W1978109678","https://openalex.org/W1980612924","https://openalex.org/W1981132320","https://openalex.org/W1982516779","https://openalex.org/W1984227891","https://openalex.org/W1984433537","https://openalex.org/W1995817686","https://openalex.org/W1999061258","https://openalex.org/W2002254893","https://openalex.org/W2009454610","https://openalex.org/W2014739371","https://openalex.org/W2016085696","https://openalex.org/W2020951538","https://openalex.org/W2025944561","https://openalex.org/W2029309391","https://openalex.org/W2037758314","https://openalex.org/W2039002107","https://openalex.org/W2040079480","https://openalex.org/W2043824774","https://openalex.org/W2047844622","https://openalex.org/W2052321977","https://openalex.org/W2052498171","https://openalex.org/W2053431736","https://openalex.org/W2054812065","https://openalex.org/W2063503631","https://openalex.org/W2067432590","https://openalex.org/W2069140826","https://openalex.org/W2071762923","https://openalex.org/W2073680876","https://openalex.org/W2074531670","https://openalex.org/W2077595053","https://openalex.org/W2080638151","https://openalex.org/W2082506593","https://openalex.org/W2091662794","https://openalex.org/W2093559687","https://openalex.org/W2101348366","https://openalex.org/W2107796877","https://openalex.org/W2110490489","https://openalex.org/W2133361358","https://openalex.org/W2134836371","https://openalex.org/W2142090603","https://openalex.org/W2152907424","https://openalex.org/W2153958083","https://openalex.org/W2159245100","https://openalex.org/W2163152072","https://openalex.org/W2163461960","https://openalex.org/W2171204153","https://openalex.org/W2329525838","https://openalex.org/W2417388512","https://openalex.org/W2429791019"],"related_works":["https://openalex.org/W1563579478","https://openalex.org/W2290719749","https://openalex.org/W1829976582","https://openalex.org/W2003835695","https://openalex.org/W2944647323","https://openalex.org/W1973755223","https://openalex.org/W4381854502","https://openalex.org/W2133361358","https://openalex.org/W2429791019","https://openalex.org/W4317387670"],"abstract_inverted_index":{"Reducing":[0],"excessive":[1],"accumulation":[2,164],"of":[3,14,20,29,33,56,127,167],"amyloid-\u03b2":[4],"(A\u03b2)":[5],"in":[6,49,107,115,130,150,165],"Alzheimer's":[7],"disease":[8],"(AD)":[9],"is":[10],"a":[11,50],"key":[12],"objective":[13],"most":[15],"AD":[16,57],"therapies,":[17],"and":[18,37,46,81,92,104,111],"inhibition":[19],"angiotensin-converting":[21],"enzyme":[22],"(ACE)":[23],"may":[24],"delay":[25],"onset":[26],"or":[27,68,134,141,156,162],"progression":[28],"AD.":[30],"The":[31],"effects":[32],"an":[34,38],"ACE-inhibitor":[35],"(ACE-I)":[36],"angiotensin":[39],"II":[40],"receptor":[41],"blocker":[42],"(ARB)":[43],"on":[44],"A\u03b2":[45,161],"tau":[47,139],"pathology":[48],"triple":[51],"transgenic":[52],"(3xTGAD)":[53],"mouse":[54],"model":[55],"were":[58,63,83,95,137],"investigated.":[59],"9-10month":[60],"3xTGAD":[61,128,169],"mice":[62,82,129],"treated":[64],"with":[65,154],"ARB,":[66],"ACE-I":[67,109,145,155],"vehicle":[69],"for":[70],"6":[71],"months.":[72],"Mean":[73],"arterial":[74],"blood":[75],"pressure":[76],"(MABP)":[77],"was":[78,98],"measured":[79],"periodically":[80],"assessed":[84],"behaviourally.":[85],"A\u03b2,":[86,138],"phospho-tau,":[87],"amyloid":[88],"precursor":[89],"protein":[90],"(APP)":[91],"ACE":[93,148],"activity":[94,149],"analysed.":[96],"MABP":[97],"significantly":[99,146],"reduced":[100,147],"at":[101,112],"2":[102],"weeks":[103],"3":[105,113],"months":[106,114],"the":[108,116],"group":[110],"ARB":[117,157],"group,":[118],"compared":[119],"to":[120],"vehicle.":[121],"Neither":[122],"drug":[123],"al-":[124],"tered":[125],"performance":[126],"Morris":[131],"Water":[132],"Maze":[133],"T-maze,":[135],"nor":[136],"immunolabelling":[140],"APP":[142],"levels":[143],"altered.":[144],"kidney.":[151],"Prolonged":[152],"treatment":[153],"does":[158],"not":[159],"affect":[160],"phospho-tau":[163],"brains":[166],"aged":[168],"mice.":[170]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}